Lucie Bruijin, Ph.D., is science director and vice president of The Amyotrophic Lateral Sclerosis (ALS) Association. This national non-profit organization is the largest private source of funding for ALS-specific scientific research in the world, having awarded nearly $30 million since 1995. Dr. Bruijin received a bachelor's degree in pharmacy from Rhodes University, South Africa, and a master's degree in neuroscience and a doctorate in biochemistry at the University of London, United Kingdom. She has developed and characterized various model systems of neurodegenerative diseases, including one of the mouse models of ALS.
Last Modified January 23, 2012